Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $90,410
Award facts
- Contract value 100% obligated
- $90,409.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $90,409.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pens on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical vendor in the federal pharmaceutical supply chain, regularly fulfilling competitively awarded contracts with the DLA for a diverse portfolio of medications across multiple therapeutic domains. As a major pharmaceutical distributor and healthcare solutions provider, the company maintains the capacity to supply brand-name and generic medications, vaccines, and specialized medical commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award of this Zepbound delivery order reflects the company's established capability to meet federal procurement requirements and its role as a key supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FJH1Q?
SPE2DR26FJH1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FJH1Q worth?
The government has obligated $90,410 on SPE2DR26FJH1Q.
Is contract SPE2DR26FJH1Q an order under another contract?
Yes. SPE2DR26FJH1Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH1Q competed?
The extent of competition for SPE2DR26FJH1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award